PharmiWeb.com - Global Pharma News & Resources

Biotech - Press Releases

Date Title Company
19-Dec-2024 NICE recommendation for KORSERDU®▼ (elacestrant) marks ‘step-change’ in the treatment of ESR1-mutated metastatic breast cancer Menarini Stemline UK
19-Dec-2024 TargED Biopharmaceuticals doses first participant in Phase 1 clinical trial of TGD001, a groundbreaking thrombolytic in acute ischemic stroke (AIS) and TTP TargED Biopharmaceuticals
19-Dec-2024 Ottimo Pharma Raises over $140 Million in Series A Financing Ottimo Pharma
19-Dec-2024 Protheragen-ING Releases Hundreds of APIs: Anti-Tumor APIs, Hypoglycemic APIs, Antipsychotic APIs, Bronchiectasis APIs, Antihypertensive APIs Protheragen-ING
19-Dec-2024 Protheragen-ING Lab Launches Comprehensive Pharmaceutical Safety Evaluation Services Protheragen-ING
19-Dec-2024 CD Formulation Announces Festive Discounts: 5%-15% Off on All Products and Services CD Formulation
19-Dec-2024 CD Formulation Reveals Specialty in Oral Thin Film Manufacturing Technologies CD Formulation
19-Dec-2024 Alfa Chemistry Expands Pharmaceutical Product Portfolio: Introducing PROTAC Building Blocks, Nucleosides, Intermediates, and APIs Alfa Chemistry
19-Dec-2024 Alfa Chemistry Demonstrates Expertise in Research, Development and Manufacture of Multiple Sputtering Targets Alfa Chemistry
17-Dec-2024 Aqilion to present at Biotech ShowcaseTM during JP Morgan week in San Fransisco Aqilion
17-Dec-2024 Tiziana Life Sciences Announces First Patient with Moderate Alzheimer’s Disease Dosed with Intranasal Foralumab Tiziana Life Sciences
17-Dec-2024 BiPER Therapeutics raises €800,000 in bridge funding to advance its first-in-class BiP-Inhibitor for gastrointestinal cancers to clinical trials Andrew Lloyd Associates
17-Dec-2024 Cizzle Biotechnology Expands Groundbreaking Early Lung Cancer Test to the Caribbean Cizzle Biotechnology
17-Dec-2024 Theolytics Appoints David Apelian MD, PhD, MBA as CEO Theolytics
16-Dec-2024 Concinnity Genetics raises £3m to establish unique RNA-based control systems for precise control of gene therapies in oversubscribed round Concinnity Genetics
13-Dec-2024 Everest Medicines Announces the First Prescription of VELSIPITY(R) Issued in Macau Everest Medicines Limited
12-Dec-2024 PDC*line Pharma presents primary clinical results of phase I/II trial on PDC*lung01 cancer vaccine Andrew Lloyd Associates
12-Dec-2024 Everest Medicines: Accelerating Innovation in Renal Disease to Forge a Path Toward Biopharma Leadership Everest Medicines
11-Dec-2024 Leriglitazone has met the primary endpoint in NEXUS, the pivotal trial for pediatric patients with cerebral Adrenoleukodystrophy Minoryx Therapeutics
11-Dec-2024 Likarda Partners With VitalTE to Develop Extended-Release Injectable Hormone Therapies Likarda Partners